COA/RT-2026-152Verified
Save as PDFCertificate of Analysis
PuriLab Analytical
Retatrutide 30 mg
RT-2026-152Lot IRX301Analyzed November 20, 2026

Timeline
Ordered
November 18, 2026
Received
November 20, 2026
Analyzed
November 20, 2026
Sample
Name
Retatrutide 30 mg
Expected
Retatrutide
Amount
1 vial, lyophilized powder
Testing
Client
David D.
Test type
Content & purity, fentanyl
Method
HPLC-UV
Content, how much is in it
33.57mg
Label claim: 30 mg
Purity, how clean it is
99.7%
Measured, not estimated. Purity is calculated from the full chromatogram shown above.
Fentanyl
NOT DETECTED
Screening cutoff 20 ng/mL
Chromatogram
HPLC-UV
13.39 min, Retatrutide, 99.7%
Analyst Comments
White lyophilized powder, purple flip-cap vial, received sealed.
Analyst Signature
Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 20, 2026
Verification Code
RT-UCZW-33X7
Verify at purilab.org/verify/RT-UCZW-33X7
Scan to Verify
RT-UCZW-33X7
Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.
PuriLab Analytical|admin@purilab.org
Page 1 of 1